A detailed history of China Universal Asset Management Co., Ltd. transactions in Meira G Tx Holdings PLC stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 14,886 shares of MGTX stock, worth $93,484. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,886
Previous 7,556 97.01%
Holding current value
$93,484
Previous $31,000 100.0%
% of portfolio
0.01%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$3.88 - $5.23 $28,440 - $38,335
7,330 Added 97.01%
14,886 $62,000
Q2 2024

Jul 19, 2024

SELL
$4.21 - $5.81 $19,744 - $27,248
-4,690 Reduced 38.3%
7,556 $31,000
Q1 2024

Apr 29, 2024

BUY
$5.78 - $7.33 $28,275 - $35,858
4,892 Added 66.52%
12,246 $74,000
Q4 2023

May 21, 2024

SELL
$3.6 - $7.15 $17,611 - $34,977
-4,892 Reduced 39.95%
7,354 $51,000
Q4 2023

Jan 23, 2024

BUY
$3.6 - $7.15 $20,995 - $41,698
5,832 Added 383.18%
7,354 $52,000
Q3 2023

May 21, 2024

BUY
$4.79 - $7.19 $3,558 - $5,342
743 Added 95.38%
1,522 $7,000
Q3 2023

Oct 30, 2023

BUY
$4.79 - $7.19 $3,558 - $5,342
743 Added 95.38%
1,522 $7,000
Q2 2023

May 21, 2024

BUY
$5.19 - $8.07 $633 - $984
122 Added 18.57%
779 $5,000
Q2 2023

Jul 27, 2023

BUY
$5.19 - $8.07 $633 - $984
122 Added 18.57%
779 $5,000
Q1 2023

May 21, 2024

BUY
$5.04 - $8.6 $1,018 - $1,737
202 Added 44.4%
657 $3,000
Q1 2023

Apr 27, 2023

BUY
$5.04 - $8.6 $1,018 - $1,737
202 Added 44.4%
657 $3,000
Q4 2022

May 21, 2024

SELL
$5.8 - $8.98 $68,387 - $105,883
-11,791 Reduced 96.28%
455 $2,000
Q4 2022

Jan 31, 2023

BUY
$5.8 - $8.98 $214 - $332
37 Added 8.85%
455 $3,000
Q3 2022

Oct 21, 2022

BUY
$7.55 - $11.25 $3,155 - $4,702
418 New
418 $4,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $283M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track China Universal Asset Management Co., Ltd. Portfolio

Follow China Universal Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.